JILL FLURY: Open Payments
NPI 1639226285 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 28 payments from 10 companies in 2025. Trend: 2023 $518 · 2024 $931 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 11 | $185 |
| ABBVIE INC. | 8 | $180 |
| BIOTRONIK NRO, Inc. | 1 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Impel Pharmaceuticals LLC | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: TEMPUS PIXEL, QULIPTA, BOTOX, Prospera, Qelbree, SPRAVATO, COBENFY, TRUDHESA.
Industry payments across TX — which companies pay providers there.
